Replay available

Zimmer Biomet Holdings, Inc. (ZBH) Q3 2025 Earnings Call

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) Q3 2025 earnings conference call, held 2025-11-05. Replay captured from the company's public earnings webcast.

Wed, November 5, 2025 at 8:30 AMendedReplay
Zimmer Biomet Holdings, Inc. (ZBH) Q3 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

David DiMartino

Senior Vice President, Investor Relations

Yvonne Tornos

Chairman, President, and CEO

Sukhia Patia

CFO & EVP, Finance, Operations, and Supply Chain

Robbie Marcus

Analyst at JP Morgan

Travis Steed

Analyst at Bank of America

David Roman

Analyst at Goldman Sachs

Caitlin Roberts

Analyst at Canaccord Genuity

Patrick Wood

Analyst at Morgan Stanley

Larry Beagleson

Analyst at Wells Fargo

Rick Wise

Analyst at Stiefel

Matt Taylor

Analyst at Jefferies

Ed Ridley

Analyst at Rothschild & Co / Redburn

Matt Mixick

Analyst at Barclays

Daniel Antofi

Analyst at UBS

Replay transcript excerpt

and welcome to the Zimmer Biomed third quarter 2025 earnings conference call. If anyone needs assistance at any time during the conference, please press the star followed by the zero. As a reminder, this conference is being recorded today, November 5th, 2025. Following today's presentation, there will be a question and answer session. At this time, all participants are in a listen-only mode. If you have a question, please press the star followed by the one on your push-button phone. I would now like to turn the conference over to David DiMartino, Senior Vice President, Investor Relations. Thank you, Operator, and good morning, everyone. Welcome to Zimmerman Biomet's third quarter 2025 earnings conference call. Joining me on today's call are Yvonne Tornos, our Chairman, President, and CEO, and Sukhia Patia, our CFO in EVP Finance, Operations, and Supply Chain. Before we get started, I'd like to remind you that our comments during this call will include forward-looking statements. Actual results may differ materially from those indicated by the forward-looking statements due to a variety of risks and uncertainties. For a detailed discussion of all these risks and uncertainties, in addition to the inherent limitations of such forward-looking statements, please refer to our ICC filings. Please note, we assume no obligation to update these forward-looking statements, even if actual results or future expectations change materially. Additionally, the discussions on this call will include certain non-GAAP financial measures, some of which are forward-looking non-GAAP financial measures. Reconciliation on these measures to the most directly comparable GAAP financial measures and an explanation of our basis for calculating these measures is included within our third quarter ea...

More from Zimmer Biomet Holdings, Inc.